LFG
BLFS icon

Larson Financial Group’s BioLife Solutions BLFS Stock Holding History

Larson Financial Group’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-4
Closed -$86 – 3458
2025
Q2 		$86 Sell
4
-33
-89% -$744 ﹤0.01% 3180
2025
Q1 		$845 Buy
37
+23
+164% +$606 ﹤0.01% 2431
2024
Q4 		$363 Sell
14
-12
-46% -$299 ﹤0.01% 2283
2024
Q3 		$651 Buy
26
+23
+767% +$543 ﹤0.01% 2073
2024
Q2 		$64 Buy
+3
New +$58 ﹤0.01% 2327

Other funds holding BLFS

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return

Larson Financial Group's BLFS Position: Q3 2025 in Review

Larson Financial Group sold out of BioLife Solutions (BLFS) in Q3 2025, closing a stake of 4 shares — an estimated $86 sold.

Larson Financial Group first reported a position in BLFS in Q2 2024 and held it in 5 quarters. The position peaked at $845 in Q1 2025. 192 funds tracked by Wall St. Rank hold BLFS as of Q3 2025.

  • Larson Financial Group reported no remaining BioLife Solutions position as of Q3 2025 after selling out during the quarter.
  • Larson Financial Group sold 4 BioLife Solutions shares in Q3 2025, an estimated $86.
  • Larson Financial Group first reported a position in BioLife Solutions in Q2 2024 and held it in 5 quarters.
  • Larson Financial Group's BioLife Solutions position peaked at $845 in Q1 2025.
  • 192 funds tracked by Wall St. Rank held BioLife Solutions as of Q3 2025.

Based on Larson Financial Group's 13F filing for Q3 2025, filed 14 Nov 2025.